The latest biotech news

News and Trends 23 May 2023

HuidaGene Therapeutics creates world’s first ‘G to Y’ DNA base-editor

HuidaGene Therapeutics, a clinical-stage genome-editing company, says the National Science Review has published data from its study of the world’s first DNA base editor converting guanine to cytosine/thymine (pyrimidine), or G-to-Y. The company has filed an international patent application for the glycosylase-based guanine base editor (gGBE) and owns the exclusive global rights to the underlying […]

May 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 23 May 2023

Ironwood acquires VectivBio in $1B deal

Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, and VectivBio Holding AG, a clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions, have entered into a definitive agreement for Ironwood to acquire VectivBio for $17.00 per share in an all-cash transaction with an estimated aggregate consideration of approximately $1 billion, net of VectivBio […]

May 23, 2023 - 5 minutesmins - By Jim Cornall

News and Trends 23 May 2023

Take part in a clinical trial? Sure, just pay me

The majority of people in the U.K. (68%) would consider taking part in a clinical trial, it has been revealed today, while half of Brits would also be willing to take part in an early phase clinical trial. Financial payment is the most popular motivation for taking part in a clinical trial, but discovering new […]

May 23, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 22 May 2023

Cancer implications as new molecule can kill ‘zombie’ cells

Over time, the body’s cells stop working properly and begin to accumulate, which eventually leads to tissues aging. Researchers at the UOC (Universitat Oberta de Catalunya) in Spain, in collaboration with the University of Leicester in the U.K. have discovered a new molecule that is able to destroy these old cells without affecting healthy ones. […]

May 22, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 22 May 2023

FDA approves first topical gene therapy for dystrophic epidermolysis bullosa wound treatment

The U.S. Food and Drug Administration has approved Vyjuvek, a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy, for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene. The approval of Vyjuvek was granted to […]

May 22, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 19 May 2023

Kelonia presents ‘compelling evidence’ for transformative multiple myeloma treatment

Kelonia Therapeutics, a biotech company working on in vivo gene delivery, has announced the results of preclinical research demonstrating that its in vivo Gene Placement System (iGPS) technology efficiently delivered CAR molecules specifically to T cells at therapeutic dose levels in both mice and non-human primates (NHPs). Kelonia’s iGPS platform enables CAR T cell therapy […]

May 19, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 19 May 2023

Swedish company develops first effective treatment for hypothyroidism

Prolevi Bio has developed a technology intended to help the 10 to 20% of people who don’t respond to current treatments for underactive thyroid glands. The company has developed a modified release thyroid hormone tablet formulation, mimicking the natural hormone release cycles. In addition, the treatment will be tailored according to each patient’s needs using […]

May 19, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 19 May 2023

Researchers make cancer weight loss pathway discovery

Nearly half of all cancer patients suffer from excessive weight loss due to the loss of adipose and skeletal muscle tissues, or cachexia. This progressive illness not only reduces quality of life for cancer patients but also poses a serious threat for treatment since it obstructs the use of effective medicines, especially in advanced stages. […]

May 19, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 19 May 2023

Google Cloud adds AI solutions for drug discovery

Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and […]

May 19, 2023 - 6 minutesmins - By Jim Cornall

News and Trends 18 May 2023

Could a salt flats pigment treat cancer?

Researchers have identified the anti-cancer capacity of a pigment present in the Santa Pola salt flats in eastern Spain. The pigment is produced by certain microorganisms, the ‘halophilic archaea’, in order to protect themselves from the sun, and its anti-tumor capacity has been tested in several types of breast cancer. The study took place at […]

May 18, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 18 May 2023

Industry responds to UK science strategy launch

The UK Health Security Agency’s (UKHSA) has launched a 10-year science strategy, setting out how science can save more lives and contribute to the U.K.’s ambition of being a global science superpower. The strategy sets out how the UKHSA scientific capabilities – including genomics, vaccine evaluation, surveillance, data science, diagnostics and toxicology – will be […]

May 18, 2023 - 7 minutesmins - By Jim Cornall

News and Trends 18 May 2023

8 rare diseases selected for gene therapy trial portfolio

The Foundation for the National Institutes of Health (FNIH) says the Accelerating Medicines Partnership Bespoke Gene Therapy Consortium (AMP BGTC) has selected eight rare diseases for its clinical trial portfolio. This portfolio pioneers a novel approach to gene therapy development for rare diseases by demonstrating that manufacturing and testing standards can provide a streamlined approval […]

May 18, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

HuidaGene Therapeutics creates world’s first ‘G to Y’ DNA base-editor

Ironwood acquires VectivBio in $1B deal

Take part in a clinical trial? Sure, just pay me

Cancer implications as new molecule can kill ‘zombie’ cells

FDA approves first topical gene therapy for dystrophic epidermolysis bullosa wound treatment

Kelonia presents ‘compelling evidence’ for transformative multiple myeloma treatment

Swedish company develops first effective treatment for hypothyroidism

Researchers make cancer weight loss pathway discovery

Google Cloud adds AI solutions for drug discovery

Could a salt flats pigment treat cancer?

Industry responds to UK science strategy launch

8 rare diseases selected for gene therapy trial portfolio

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!